Search - tctmd.com

Displaying 461 - 480 of 1123

Sort: Relevancy | Date

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Conference News ISET 2017

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

Caitlin E. Cox

February 13, 2017

Presentation JIM 2017

Bioresorbable Scaffolds is a Real Need:CONTRA

Presenter: Robert A. Byrne

February 10, 2017

Presentation JIM 2017

Bioresorbable Scaffolds: A Real Clinical Need? Yes!

Presenter: Gregg W. Stone

February 10, 2017

Presentation JIM 2017

“Clinical Outcome and My Experience of MeRes 100 BioResorbable Scaffold”

Presenter: Sasko Kedev

February 10, 2017

Presentation JIM 2017

Bioresorbable Scaffolds: An Important Clinical Need

Presenter: Gregg W. Stone

February 08, 2017

Presentation JIM 2017

Magmaris a Magnesium Based Bioreorbable Scaffold

Presenter: Ron Waksman

February 08, 2017

Presentation JIM 2017

FANTOM: A Radio-opaque Desaminotyrosine Polycarbonate-based Scaffold

Presenter: Gregg W. Stone

February 08, 2017

Presentation JIM 2017

MeRes 100: A Thin-Strut PLLA-based Scaffold

Presenter: Martin B. Leon

February 08, 2017

Presentation JIM 2017

FORTITUDE, APTITUDE and MAGNITUDE: Other Thin-Strut Novel PLLA-Based Scaffolds

Presenter: Azeem Latib

February 08, 2017

Presentation JIM 2017

DESolve: A Family of Novel PLLA-Based Scaffolds

Presenter: Martin B. Leon

February 08, 2017

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox

February 07, 2017

Presentation ISET 2017

Bioabsorbable Scaffolds for Peripheral Applications: What Do We Know?

Presenter: MIchael D. Dake

February 06, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

Presentation

Efficacy and Safety of the Absorb Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Absorb Diabetic Substudy

Presenter: D. Kereiakes

December 23, 2016

Presentation Cardiovascular Interventions 2016

Understanding the ABSORB Bioresorbable Vascular Scaffold: The Next Revolution in PCI

Presenter: David G. Rizik

November 10, 2016

Advertisement

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

Bioresorbable Scaffolds is a Real Need:CONTRA

Bioresorbable Scaffolds: A Real Clinical Need? Yes!

“Clinical Outcome and My Experience of MeRes 100 BioResorbable Scaffold”

Bioresorbable Scaffolds: An Important Clinical Need

Magmaris a Magnesium Based Bioreorbable Scaffold

FANTOM: A Radio-opaque Desaminotyrosine Polycarbonate-based Scaffold

MeRes 100: A Thin-Strut PLLA-based Scaffold

FORTITUDE, APTITUDE and MAGNITUDE: Other Thin-Strut Novel PLLA-Based Scaffolds

DESolve: A Family of Novel PLLA-Based Scaffolds

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Bioabsorbable Scaffolds for Peripheral Applications: What Do We Know?

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

TCTMD’s Top 10 Most Popular News and Features for 2016

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Efficacy and Safety of the Absorb Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Absorb Diabetic Substudy

Understanding the ABSORB Bioresorbable Vascular Scaffold: The Next Revolution in PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content